systematic_review
    2015

    Luteolin, a flavonoid with potential anti-inflammatory and neuroprotective activity: a review of mechanisms and clinical evidence

    Nabavi SF, Braidy N, Gortzi O

    Published in Brain Research Bulletin

    Key Findings

    Luteolin inhibits NF-kB signalling and mast cell activation in preclinical models, with human clinical evidence still very limited.

    Conclusions

    Mechanistically promising, clinically unproven.

    Limitations

    Predominantly preclinical evidence.

    Supplements Studied

    Luteolin inhibits NF-kB signalling and mast cell activation in preclinical models, with human clinical evidence still very limited.

    Related Health Concerns

    Chronic Inflammation

    Study Details

    Year:2015
    Quality Score:5/10

    Access Study

    View on DOIView on PubMedOriginal Source

    This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.